Search research articles
Contact Us
Filters
Showing results (1-10 of 49) with videos related to
Page
of 5
Sort By:
British Journal of Haematology
|
January 8, 2024
Tri-ing to decipher trisomy AML
Shai Shimony, Evan C Chen
Blood Advances
|
January 13, 2026
More than CLK bait? Rogocekib for MDS and AML
Evan C Chen, Maximilian Stahl
Acta Haematologica
|
September 6, 2023
Immunotherapy for Acute Myeloid Leukemia: Current Trends, Challenges, and Strategies
Evan C Chen, Jacqueline S Garcia
Hematology. American Society of Hematology. Education Program
|
December 4, 2020
Does patient fitness play a role in determining first-line treatment of acute myeloid leukemia?
Evan C Chen, Jacqueline S Garcia
Current Hematologic Malignancy Reports
|
January 27, 2023
Targeted Therapy for MPNs: Going Beyond JAK Inhibitors
Evan C Chen, Hannah Johnston, Anand Ashwin Patel
Oncotargets and Therapy
|
June 22, 2018
Reformulating acute myeloid leukemia: liposomal cytarabine and daunorubicin (CPX-351) as an emerging therapy for secondary AML
Evan C Chen, Amir T Fathi, Andrew M Brunner
Blood Reviews
|
November 10, 2022
Prognostication in myelodysplastic syndromes (neoplasms): Molecular risk stratification finally coming of age
Zhuoer Xie, Evan C Chen, Maximilian Stahl, et al.
American Journal of Hematology
|
February 4, 2025
Biology and Management of Acute Myeloid Leukemia With Mutated NPM1
Evan C Chen, Shai Shimony, Marlise R Luskin, et al.
Substance Abuse
|
January 29, 2016
A case of butane hash oil (marijuana wax)-induced psychosis
Corey J Keller, Evan C Chen, Kimberly Brodsky, et al.
European Journal of Haematology
|
January 23, 2026
Challenges and Solutions to Implementation of Chimeric Antigen Receptor Therapies in Acute Myeloid Leukemia
Shivahamy Maheswaran, Caroline D Gordon, Evan C Chen, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 49) with videos related to
Sort By:
Page
of 5
British Journal of Haematology
|
January 8, 2024
Tri-ing to decipher trisomy AML
Shai Shimony, Evan C Chen
Blood Advances
|
January 13, 2026
More than CLK bait? Rogocekib for MDS and AML
Evan C Chen, Maximilian Stahl
Acta Haematologica
|
September 6, 2023
Immunotherapy for Acute Myeloid Leukemia: Current Trends, Challenges, and Strategies
Evan C Chen, Jacqueline S Garcia
Hematology. American Society of Hematology. Education Program
|
December 4, 2020
Does patient fitness play a role in determining first-line treatment of acute myeloid leukemia?
Evan C Chen, Jacqueline S Garcia
Current Hematologic Malignancy Reports
|
January 27, 2023
Targeted Therapy for MPNs: Going Beyond JAK Inhibitors
Evan C Chen, Hannah Johnston, Anand Ashwin Patel
Oncotargets and Therapy
|
June 22, 2018
Reformulating acute myeloid leukemia: liposomal cytarabine and daunorubicin (CPX-351) as an emerging therapy for secondary AML
Evan C Chen, Amir T Fathi, Andrew M Brunner
Blood Reviews
|
November 10, 2022
Prognostication in myelodysplastic syndromes (neoplasms): Molecular risk stratification finally coming of age
Zhuoer Xie, Evan C Chen, Maximilian Stahl, et al.
American Journal of Hematology
|
February 4, 2025
Biology and Management of Acute Myeloid Leukemia With Mutated NPM1
Evan C Chen, Shai Shimony, Marlise R Luskin, et al.
Substance Abuse
|
January 29, 2016
A case of butane hash oil (marijuana wax)-induced psychosis
Corey J Keller, Evan C Chen, Kimberly Brodsky, et al.
European Journal of Haematology
|
January 23, 2026
Challenges and Solutions to Implementation of Chimeric Antigen Receptor Therapies in Acute Myeloid Leukemia
Shivahamy Maheswaran, Caroline D Gordon, Evan C Chen, et al.
Page
of 5